Blue Trust Inc. Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Trust Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,862 shares of the medical equipment provider’s stock after buying an additional 395 shares during the period. Blue Trust Inc.’s holdings in Intuitive Surgical were worth $2,408,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $6,509,000. Bank of Stockton raised its position in shares of Intuitive Surgical by 13.5% in the fourth quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after buying an additional 138 shares during the last quarter. Bank Pictet & Cie Europe AG raised its position in shares of Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock valued at $99,678,000 after buying an additional 883 shares during the last quarter. Finally, D.A. Davidson & CO. lifted its stake in shares of Intuitive Surgical by 0.9% in the fourth quarter. D.A. Davidson & CO. now owns 13,198 shares of the medical equipment provider’s stock worth $6,889,000 after buying an additional 115 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Truist Financial dropped their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Robert W. Baird cut their price target on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Piper Sandler lowered their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $588.95.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $509.49 on Friday. The company’s 50 day simple moving average is $527.71 and its 200-day simple moving average is $537.69. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The company has a market capitalization of $182.61 billion, a price-to-earnings ratio of 74.71, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the company earned $1.50 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.